Stanford Cancer Institute Clinical Trials Office Blog

News & Updates from the SCI-CTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • SCI Clinical Trials Office
  • Stanford Cancer Institute

Join the DSMC admin team in the Zoom Virtual Chat every Wednesday from 9:30-10 am.

May 11, 2023 - SCI Communications

The DSMC admin team is excited to share the initiation of a dedicated time to answer any questions you may have for them. We would like to invite you all to a Zoom Virtual Chat that we are starting as a bi-monthly, walk-in Zoom session(s). 

Our first Zoom chat will be May 17, 2023 (Wednesday) from 9.30 to 10.30 am, and we hope to see you there!

No need for appointments! Just log in using the Zoom link below and ask us any questions you may have regarding DSMC related queries or if you need clarification regarding DSMC actions or any questions you may have regarding DSMC processes. 

Please note, this is separate from the quality Zoom Virtual Chats that are hosted by the quality monitors every Wednesday from 9-9:30 am.

Zoom Link: Zoom chats will be held every 2 weeks starting May 17, 2023 (Wednesdays from 9.30 to 10.30 am);

https://stanford.zoom.us/j/99486264317?pwd=UDkwcmJvK2ZEUE1STldFb2x1U1FDUT09&from=addon

If you are unable to join the Zoom virtual chat, please send your question to dsmc-office@stanford.edu

Looking forward to chatting with you!

DSMC admin team

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • PRISM
  • PRMS
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube